HHS IG To Study EPO, OxyContin Reimbursement In 2004 Reports
Executive Summary
The HHS' Inspector General plans to study the "appropriateness" of epoetin alfa Medicare reimbursements for patients who have not been diagnosed with end stage renal disease
You may also be interested in...
EPO Reimbursement Report Suggests $10 Per Unit Is Close To Market Price
Actual market prices for Amgen's Epogen in the dialysis market range from $8.79 per unit to $9.50 per unit for most purchases, HHS' Office of the Inspector General said in a May 5 report
EPO Reimbursement Report Suggests $10 Per Unit Is Close To Market Price
Actual market prices for Amgen's Epogen in the dialysis market range from $8.79 per unit to $9.50 per unit for most purchases, HHS' Office of the Inspector General said in a May 5 report
OIG To Study AWP Prices For Physician-Administered Drugs
The HHS Office of the Inspector General will conduct studies of AWP with the aim of allowing state Medicaid programs to reimburse physician-administered drugs at a lower price